Skip to content
  • 6,797 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Justification

Travis AFB, David Grant Medical Center, Coagulation Analyzer (Phase -In/Phase-Out)

FA442724P0117

Department of the Air Force, FA4427 60 Cons LGC. In-Vitro Diagnostic Substance Manufacturing.

13 open like this View on SAM.gov Markdown

Awarded

Abbott Laboratories Inc.

$200,099.68 obligated so far on USAspending, August 30, 2024, contract FA442724P0117

Get the next one like this from Department of the Air Force by email, the day it is posted.Find my opportunities

This one was awarded in 2024

13 like it are open now in in-vitro diagnostic substance manufacturing

All 13 open in in-vitro diagnostic substance manufacturing

Description

As published on SAM.gov.

The 60th Medical Group (60 MDG) at Travis Air Force Base has a requirement to maintain the current Coagulation Analyzer operational, while the new contract Analyzer is Phased-In. Abbott laboratories Inc. is the incumbent Coagulation Analyzer under contract.

As the follow-on contract was awarded to another Vendor, DGMC requires incumbent Coagulation Analyzer to remain in the facility while new vendor transitions their equipment in, so there is no loss of testing capabilities during the estimated 6 month Phase In/Phase Out timeline. The current contractor (Abbott) must uninstall and remove its equipment, and the new contractor (Werfen) must install and validate its new equipment in this 6-month period. 60 MDG requires continuous lab testing capability during this phase-out / phase-in period.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Abbott Laboratories Inc.
UEI
NH3LDK8CFAK7
CAGE
33110
Vendor location
Abbott Park, IL
Contract
FA442724P0117, purchase order
Obligated
$200,099.68
Actions
4 between August 30, 2024 and January 26, 2026
Competition
Not Competed, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
PKB - Coagulation Onboarding Services
Match
award number FA442724P0117 equals the contract number; same awarding office FA4427 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 30, 2024

    Justification

    SAM.gov, notice 432d7286c37743e48ccceb6a24843748

Points of contact